Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) insider Marissa Brittenham sold 3,156 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $24.09, for a total transaction of $76,028.04. Following the transaction, the insider now directly owns 63,408 shares of the company's stock, valued at approximately $1,527,498.72. This trade represents a 4.74 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Surgery Partners Stock Performance
NASDAQ:SGRY opened at $23.61 on Friday. Surgery Partners, Inc. has a twelve month low of $19.50 and a twelve month high of $33.97. The firm has a market capitalization of $3.01 billion, a price-to-earnings ratio of -49.19, a PEG ratio of 19.21 and a beta of 2.73. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The firm's fifty day simple moving average is $23.53 and its 200 day simple moving average is $26.14.
Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its earnings results on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating the consensus estimate of $0.38 by $0.01. The business had revenue of $864.40 million for the quarter, compared to the consensus estimate of $828.09 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. As a group, equities research analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of research firms recently commented on SGRY. Macquarie decreased their price objective on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research note on Tuesday. Royal Bank of Canada decreased their price objective on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating on the stock in a report on Wednesday, November 20th. JPMorgan Chase & Co. dropped their target price on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating for the company in a research note on Tuesday, December 3rd. Finally, Bank of America initiated coverage on Surgery Partners in a research note on Monday, December 16th. They issued a "buy" rating and a $30.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $36.63.
Check Out Our Latest Research Report on SGRY
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in SGRY. Principal Financial Group Inc. acquired a new position in Surgery Partners in the 3rd quarter worth $1,469,000. State of New Jersey Common Pension Fund D acquired a new stake in Surgery Partners during the 3rd quarter valued at approximately $1,968,000. Versor Investments LP acquired a new position in shares of Surgery Partners in the 3rd quarter valued at approximately $271,000. Victory Capital Management Inc. grew its position in shares of Surgery Partners by 140.4% during the third quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company's stock worth $42,892,000 after buying an additional 777,038 shares in the last quarter. Finally, KBC Group NV increased its stake in shares of Surgery Partners by 31.8% in the third quarter. KBC Group NV now owns 2,385 shares of the company's stock worth $77,000 after buying an additional 576 shares during the last quarter.
Surgery Partners Company Profile
(
Get Free Report)
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
